Arax Advisory Partners’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$876	Sell	18 -25	-58%	-$1.22K	﹤0.01%	2817
2025 Q1	$1.46K	Buy	+43	New	+$1.46K	﹤0.01%	2180
2022 Q4	–	Sell	-40	Closed	-$3K	–	1285
2022 Q3	$3K	Hold	40	–	–	﹤0.01%	890
2022 Q2	$2K	Buy	+40	New	+$2K	﹤0.01%	936